KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Gains from Investment Securities (2016 - 2026)

Elevance Health has reported Gains from Investment Securities over the past 18 years, most recently at $34.0 million for Q1 2026.

  • Quarterly Gains from Investment Securities fell 72.36% to $34.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$57.0 million through Mar 2026, down 128.08% year-over-year, with the annual reading at $32.0 million for FY2025, 70.64% down from the prior year.
  • Gains from Investment Securities was $34.0 million for Q1 2026 at Elevance Health, up from $1.0 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $123.0 million in Q1 2025 and troughed at -$85.0 million in Q2 2025.
  • The 5-year median for Gains from Investment Securities is $28.5 million (2022), against an average of $24.6 million.
  • Peak annual rise in Gains from Investment Securities hit 473.33% in 2022, while the deepest fall reached 300.0% in 2022.
  • Tracing ELV's Gains from Investment Securities over 5 years: stood at $29.0 million in 2022, then soared by 82.76% to $53.0 million in 2023, then tumbled by 75.47% to $13.0 million in 2024, then tumbled by 92.31% to $1.0 million in 2025, then skyrocketed by 3300.0% to $34.0 million in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $34.0 million, $1.0 million, and -$7.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.